Literature DB >> 15333851

Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath.

C Lane1, D Knight, S Burgess, P Franklin, F Horak, J Legg, A Moeller, S Stick.   

Abstract

BACKGROUND: The fractional concentration of nitric oxide (NO) in exhaled breath (FeNO) is increased in asthma. There is a general assumption that NO synthase (NOS) 2 in epithelium is the main source of NO in exhaled breath. However, there is no direct evidence to support the assumption and data from animal models suggest that non-inducible NOS systems have important roles in determining airway reactivity, regulating inflammation, and might contribute significantly to NO measured in exhaled breath.
METHODS: Bronchial epithelial cells were obtained from healthy, atopic, and asthmatic children by non-bronchoscopic brushing. Exhaled NO (FeNO) was measured directly using a fast response chemiluminescence NO analyser. RNA was extracted from the epithelial cells and real time polymerase chain reaction was used to determine the expression of NOS isoenzymes. NOS2 was examined in macrophages and epithelial cells by immunohistochemistry.
RESULTS: NOS1 mRNA was not detectable. NOS3 mRNA was detected in 36 of 43 samples at lower levels than NOS2 mRNA which was detectable in all samples. The median FeNO was 15.5 ppb (95% CI 10 to 18.1). There was a significant correlation between FeNO and NOS2 expression (R = 0.672, p<0.001). All epithelial cells exhibited NOS2 staining, whereas staining in the macrophages was variable and not related to phenotype.
CONCLUSIONS: Only NOS2 expression was associated with FeNO in respiratory epithelial cells obtained from children (R = 0.672; p<0.001). This suggests that FeNO variability is largely determined by epithelial NOS2 expression with little contribution from other isoforms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15333851      PMCID: PMC1747143          DOI: 10.1136/thx.2003.014894

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Intraindividual peak flow variability.

Authors:  M J Hegewald; R O Crapo; R L Jensen
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

2.  Complex regulation of human neuronal nitric-oxide synthase exon 1c gene transcription. Essential role of Sp and ZNF family members of transcription factors.

Authors:  Dieter Saur; Barbara Seidler; Heidi Paehge; Volker Schusdziarra; Hans-Dieter Allescher
Journal:  J Biol Chem       Date:  2002-04-17       Impact factor: 5.157

3.  A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.

Authors:  Trevor T Hansel; Sergei A Kharitonov; Louise E Donnelly; Edward M Erin; Mark G Currie; William M Moore; Pamela T Manning; David P Recker; Peter J Barnes
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

4.  Nitric oxide airway diffusing capacity and mucosal concentration in asthmatic schoolchildren.

Authors:  Christophe Pedroletti; Marieann Högman; Pekka Meriläinen; Lennart S Nordvall; Gunilla Hedlin; Kjell Alving
Journal:  Pediatr Res       Date:  2003-07-02       Impact factor: 3.756

5.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization.

Authors:  L Kobzik; D S Bredt; C J Lowenstein; J Drazen; B Gaston; D Sugarbaker; J S Stamler
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

6.  Increased eNO and pulmonary iNOS expression in eNOS null mice.

Authors:  S Cook; P Vollenweider; B Ménard; M Egli; P Nicod; U Scherrer
Journal:  Eur Respir J       Date:  2003-05       Impact factor: 16.671

7.  Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections.

Authors:  S A Kharitonov; D Yates; P J Barnes
Journal:  Eur Respir J       Date:  1995-02       Impact factor: 16.671

8.  Reduction of neuronal and inducible nitric oxide synthase gene expression in patients with cystic fibrosis.

Authors:  Jörg Dötsch; Jan Puls; Thorsten Klimek; Wolfgang Rascher
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-04       Impact factor: 2.503

9.  Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia.

Authors:  Claudia Jakubzick; Esther S Choi; Kristin J Carpenter; Steven L Kunkel; Holly Evanoff; Fernando J Martinez; Kevin R Flaherty; Galen B Toews; Thomas V Colby; William D Travis; Bharat H Joshi; Raj K Puri; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells.

Authors:  K Asano; C B Chee; B Gaston; C M Lilly; C Gerard; J M Drazen; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more
  66 in total

Review 1.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

2.  Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.

Authors:  Otgonchimeg Rentsendorj; Franco R D'Alessio; David B Pearse
Journal:  J Leukoc Biol       Date:  2014-07-25       Impact factor: 4.962

Review 3.  Nitric oxide metabolism in asthma pathophysiology.

Authors:  Sudakshina Ghosh; Serpil C Erzurum
Journal:  Biochim Biophys Acta       Date:  2011-06-21

4.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 5.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 6.  Predictive Biomarkers for Asthma Therapy.

Authors:  Sarah K Medrek; Amit D Parulekar; Nicola A Hanania
Journal:  Curr Allergy Asthma Rep       Date:  2017-09-19       Impact factor: 4.806

7.  Increased Sputum IL-17A Level in Non-asthmatic Eosinophilic Bronchitis.

Authors:  Chen Zhan; Rong Xu; Jiaxing Liu; Shengfang Zhang; Wei Luo; Ruchong Chen; Kefang Lai
Journal:  Lung       Date:  2018-10-01       Impact factor: 2.584

8.  Biomarker-based asthma phenotypes of corticosteroid response.

Authors:  Douglas C Cowan; D Robin Taylor; Laura E Peterson; Jan O Cowan; Rochelle Palmay; Avis Williamson; Jef Hammel; Serpil C Erzurum; Stanley L Hazen; Suzy A A Comhair
Journal:  J Allergy Clin Immunol       Date:  2014-12-06       Impact factor: 10.793

9.  l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells.

Authors:  D Winnica; L G Que; C Baffi; H Grasemann; K Fiedler; Z Yang; E Etling; K Wasil; S E Wenzel; B Freeman; F Holguin
Journal:  Clin Exp Allergy       Date:  2016-10-04       Impact factor: 5.018

10.  L-arginine reverses cigarette-induced reduction of fractional exhaled nitric oxide in asthmatic smokers.

Authors:  C T Bruce; D Zhao; D H Yates; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2009-10-18       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.